1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 11 JANUARY 2016

Cancer Drug News 11 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Baxalta's Future Lies In Diversity
Industry Trend Analysis - NanoString Drives Growth Through Companion Diagnostics
Industry Brief - ARIAD/Otsuka Submit Iclusig NDA In Japan For Leukaemia
Industry Brief - CTI/Baxalta Complete Rolling NDA Submission For Pacritinib In MF
Industry Brief - Transgene Initiates Phase III Trial Of Pexa-Vec In HCC
Industry Brief - FDA Grants Fast Track Designation For Seviteronel In MCRPCA
Industry Brief - Merck/Biocartis Collaborate To Develop RAS Liquid Biopsy For MCRC
Industry Brief - Gem's Lead Sarcoma Candidate Granted FDA ODD
Industry Trend Analysis - Sanofi Seeking Innovative Differentiation To Grow
Industry Brief - F-star/AbbVie Sign Licensing Deal To Develop Bispecific Abs In Immuno-Oncology
Industry Brief - Immune Design Receives ODD For Complementary Components Of CMB305
Industry Brief - Pfizer/Adaptive Enter Translational Research Collaboration
Industry Brief - Teva/Checkpoint Enter Licence Agreement for Oral PARP Inhibitor
Industry Brief - OXiGENE's CA4P Gains FDA ODD For Neuroendocrine Tumours
Industry Brief - Complix/MSD Collaborate To Develop Alphabodies
Industry Brief - Cell Therapy Catapult Partners To Develop CAR-T Therapies
Industry Brief - Oncodesign/BMS Enter Drug Discovery Collaboration
Industry Trend Analysis - Precision Medicine Reinvigorating Pfizer

Table Of Contents

Cancer Drug News 11 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.